fingolimod hydrochloride has been researched along with Weight Gain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Liu, D; Qu, S; Song, K; Yan, L | 1 |
| Hupfeld, CJ; Kendall, MR | 1 |
| Afford, SC; Antoniou, EA; D'Silva, M; McMaster, P; Pirenne, J; Suzuki, S; Xu, M | 1 |
3 other study(ies) available for fingolimod hydrochloride and Weight Gain
| Article | Year |
|---|---|
Modulation of Cell-Mediated Immunity to Suppress High Fat Diet-Induced Obesity and Insulin Resistance.
Topics: Animals; Cyclosporine; Diet, High-Fat; Fingolimod Hydrochloride; Gene Expression Regulation; Immunity, Cellular; Immunosuppressive Agents; Insulin Resistance; Mice, Inbred C57BL; Obesity; Weight Gain | 2016 |
FTY720, a sphingosine-1-phosphate receptor modulator, reverses high-fat diet-induced weight gain, insulin resistance and adipose tissue inflammation in C57BL/6 mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Fingolimod Hydrochloride; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin Resistance; Lymphopenia; Male; Mice; Mice, Inbred C57BL; Panniculitis; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Weight Gain | 2008 |
Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation.
Topics: Abdomen; Animals; Drug Administration Schedule; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Intraoperative Period; Kidney Function Tests; Liver Function Tests; Propylene Glycols; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Regression Analysis; Sphingosine; Tacrolimus; Transplantation, Heterotopic; Transplantation, Homologous; Weight Gain | 1997 |